Open AccessODAC Narrowly Declines to Recommend Avastin for Metastatic Breast Cancer
Author(s) -
Margot J. Fromer
Publication year - 2008
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000308752.79875.ac
Subject(s) - bevacizumab , medicine , metastatic breast cancer , clinical endpoint , oncology , breast cancer , progression free survival , cancer , clinical trial , lung cancer , surrogate endpoint , surgery , chemotherapy